Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status

G. Giannini, C. J. Kim, L. Di Marcotullio, G. Manfioletti, B. Cardinali, F. Cerignoli, E. Ristori, M. Zani, L. Frati, I. Screpanti, A. Gulino

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

HMGI and HMGY are splicing variants of the HMGI(Y) gene and together with HMGI-C, belong to a family of DNA binding proteins involved in maintaining active chromatin conformation and in the regulation of gene transcription. The expression of the HMGI(Y) gene is maximal during embryonic development, declines in adult differentiated tissues and is reactivated in most transformed cells in vitro and in many human cancers in vivo. The HMGI(Y) genomic locus is frequently rearranged in mesenchymal tumours, suggesting a biological role for HMGI(Y) gene products in tumour biology. HMGIs are both target and modulators of retinoic acid activity. In fact, HMGI(Y) gene expression is differentially regulated by retinoic acid in retinoid-sensitive and -resistant neuroblastoma cells, while HMGI-C participates in conferring retinoic acid resistance in some neuroblastoma cells. In this paper we show that HMGI and HMGY isoforms are equally regulated by retinoic acid in neuroblastoma cell lines at both RNA and protein levels. More importantly our immunohistochemical analysis shows that, although HMGI(Y) is expressed in all neuroblastic tumours, consistently higher levels are observed in less differentiated neuroblastomas compared to more differentiated ganglioneuromas, indicating that HMGI(Y) expression should be evaluated as a potential diagnostic and prognostic marker in neuroblastic tumours. (C) 2000 Cancer Research Campaign.

Original languageEnglish
Pages (from-to)1503-1509
Number of pages7
JournalBritish Journal of Cancer
Volume83
Issue number11
Publication statusPublished - 2000

Fingerprint

HMGA1a Protein
Tretinoin
Neuroblastoma
Neoplasms
Ganglioneuroma
Genes
Retinoids
DNA-Binding Proteins
Chromatin
Embryonic Development
Protein Isoforms
RNA
Gene Expression
Cell Line

Keywords

  • HMGI
  • Neuroblastic tumours
  • Retinoic acid

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Giannini, G., Kim, C. J., Marcotullio, L. D., Manfioletti, G., Cardinali, B., Cerignoli, F., ... Gulino, A. (2000). Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. British Journal of Cancer, 83(11), 1503-1509.

Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. / Giannini, G.; Kim, C. J.; Marcotullio, L. Di; Manfioletti, G.; Cardinali, B.; Cerignoli, F.; Ristori, E.; Zani, M.; Frati, L.; Screpanti, I.; Gulino, A.

In: British Journal of Cancer, Vol. 83, No. 11, 2000, p. 1503-1509.

Research output: Contribution to journalArticle

Giannini, G, Kim, CJ, Marcotullio, LD, Manfioletti, G, Cardinali, B, Cerignoli, F, Ristori, E, Zani, M, Frati, L, Screpanti, I & Gulino, A 2000, 'Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status', British Journal of Cancer, vol. 83, no. 11, pp. 1503-1509.
Giannini G, Kim CJ, Marcotullio LD, Manfioletti G, Cardinali B, Cerignoli F et al. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. British Journal of Cancer. 2000;83(11):1503-1509.
Giannini, G. ; Kim, C. J. ; Marcotullio, L. Di ; Manfioletti, G. ; Cardinali, B. ; Cerignoli, F. ; Ristori, E. ; Zani, M. ; Frati, L. ; Screpanti, I. ; Gulino, A. / Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. In: British Journal of Cancer. 2000 ; Vol. 83, No. 11. pp. 1503-1509.
@article{8927d6ce2d5b49f79da35854846ca23c,
title = "Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status",
abstract = "HMGI and HMGY are splicing variants of the HMGI(Y) gene and together with HMGI-C, belong to a family of DNA binding proteins involved in maintaining active chromatin conformation and in the regulation of gene transcription. The expression of the HMGI(Y) gene is maximal during embryonic development, declines in adult differentiated tissues and is reactivated in most transformed cells in vitro and in many human cancers in vivo. The HMGI(Y) genomic locus is frequently rearranged in mesenchymal tumours, suggesting a biological role for HMGI(Y) gene products in tumour biology. HMGIs are both target and modulators of retinoic acid activity. In fact, HMGI(Y) gene expression is differentially regulated by retinoic acid in retinoid-sensitive and -resistant neuroblastoma cells, while HMGI-C participates in conferring retinoic acid resistance in some neuroblastoma cells. In this paper we show that HMGI and HMGY isoforms are equally regulated by retinoic acid in neuroblastoma cell lines at both RNA and protein levels. More importantly our immunohistochemical analysis shows that, although HMGI(Y) is expressed in all neuroblastic tumours, consistently higher levels are observed in less differentiated neuroblastomas compared to more differentiated ganglioneuromas, indicating that HMGI(Y) expression should be evaluated as a potential diagnostic and prognostic marker in neuroblastic tumours. (C) 2000 Cancer Research Campaign.",
keywords = "HMGI, Neuroblastic tumours, Retinoic acid",
author = "G. Giannini and Kim, {C. J.} and Marcotullio, {L. Di} and G. Manfioletti and B. Cardinali and F. Cerignoli and E. Ristori and M. Zani and L. Frati and I. Screpanti and A. Gulino",
year = "2000",
language = "English",
volume = "83",
pages = "1503--1509",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status

AU - Giannini, G.

AU - Kim, C. J.

AU - Marcotullio, L. Di

AU - Manfioletti, G.

AU - Cardinali, B.

AU - Cerignoli, F.

AU - Ristori, E.

AU - Zani, M.

AU - Frati, L.

AU - Screpanti, I.

AU - Gulino, A.

PY - 2000

Y1 - 2000

N2 - HMGI and HMGY are splicing variants of the HMGI(Y) gene and together with HMGI-C, belong to a family of DNA binding proteins involved in maintaining active chromatin conformation and in the regulation of gene transcription. The expression of the HMGI(Y) gene is maximal during embryonic development, declines in adult differentiated tissues and is reactivated in most transformed cells in vitro and in many human cancers in vivo. The HMGI(Y) genomic locus is frequently rearranged in mesenchymal tumours, suggesting a biological role for HMGI(Y) gene products in tumour biology. HMGIs are both target and modulators of retinoic acid activity. In fact, HMGI(Y) gene expression is differentially regulated by retinoic acid in retinoid-sensitive and -resistant neuroblastoma cells, while HMGI-C participates in conferring retinoic acid resistance in some neuroblastoma cells. In this paper we show that HMGI and HMGY isoforms are equally regulated by retinoic acid in neuroblastoma cell lines at both RNA and protein levels. More importantly our immunohistochemical analysis shows that, although HMGI(Y) is expressed in all neuroblastic tumours, consistently higher levels are observed in less differentiated neuroblastomas compared to more differentiated ganglioneuromas, indicating that HMGI(Y) expression should be evaluated as a potential diagnostic and prognostic marker in neuroblastic tumours. (C) 2000 Cancer Research Campaign.

AB - HMGI and HMGY are splicing variants of the HMGI(Y) gene and together with HMGI-C, belong to a family of DNA binding proteins involved in maintaining active chromatin conformation and in the regulation of gene transcription. The expression of the HMGI(Y) gene is maximal during embryonic development, declines in adult differentiated tissues and is reactivated in most transformed cells in vitro and in many human cancers in vivo. The HMGI(Y) genomic locus is frequently rearranged in mesenchymal tumours, suggesting a biological role for HMGI(Y) gene products in tumour biology. HMGIs are both target and modulators of retinoic acid activity. In fact, HMGI(Y) gene expression is differentially regulated by retinoic acid in retinoid-sensitive and -resistant neuroblastoma cells, while HMGI-C participates in conferring retinoic acid resistance in some neuroblastoma cells. In this paper we show that HMGI and HMGY isoforms are equally regulated by retinoic acid in neuroblastoma cell lines at both RNA and protein levels. More importantly our immunohistochemical analysis shows that, although HMGI(Y) is expressed in all neuroblastic tumours, consistently higher levels are observed in less differentiated neuroblastomas compared to more differentiated ganglioneuromas, indicating that HMGI(Y) expression should be evaluated as a potential diagnostic and prognostic marker in neuroblastic tumours. (C) 2000 Cancer Research Campaign.

KW - HMGI

KW - Neuroblastic tumours

KW - Retinoic acid

UR - http://www.scopus.com/inward/record.url?scp=0033665982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033665982&partnerID=8YFLogxK

M3 - Article

C2 - 11076660

AN - SCOPUS:0033665982

VL - 83

SP - 1503

EP - 1509

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 11

ER -